Chemed Corporation (NYSE: CHE) reported Q2 EPS of $6.06, $0.46 better than the analyst estimate of $5.60. Revenue for the quarter came in at $673.25 million versus the consensus estimate of $665.04 million.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.